Best Practices in Formulation and Lyo Development

Overview


Baxter-Healthcare-Corporation-WP-Pharma-2017-Best-Practices-in-Formulation-and-Lyo-Development.jpg

The ultimate goal of formulation development is a stable product. In the case of a protein product, that can be defined as delivering the correct dose, in the native secondary and tertiary structure, without unintended chemical modifications, and free of extrinsic and intrinsic particles. In many cases, a lyophilized formulation can provide the highest probability of technical success. A well-designed product development plan can develop a phase 1 product quickly, while laying the foundation for commercial product success.

This content is provided by Baxter BioPharma Solutions, and any views and opinions expressed do not necessarily reflect those of Biopharma-Reporter.com

Download Now


Related Resources

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Content provided by Baxter BioPharma Solutions

White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the available options and provides some considerations for developing & manufacturing the product.

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Content provided by Baxter BioPharma Solutions

White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain selection. The timeline for development of a seasonal influenza vaccine...

Supplier Info Centre

Baxter-BioPharma-Solutions.png

For more product information visit Baxter BioPharma Solutions.